BR0210547A - Método e material para tratar doenças imunes - Google Patents

Método e material para tratar doenças imunes

Info

Publication number
BR0210547A
BR0210547A BR0210547-0A BR0210547A BR0210547A BR 0210547 A BR0210547 A BR 0210547A BR 0210547 A BR0210547 A BR 0210547A BR 0210547 A BR0210547 A BR 0210547A
Authority
BR
Brazil
Prior art keywords
galectin
backbone
organism
binds
therapeutic
Prior art date
Application number
BR0210547-0A
Other languages
English (en)
Portuguese (pt)
Inventor
Yang Chang
Vodek Sasek
Original Assignee
Glycogenesys Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glycogenesys Inc filed Critical Glycogenesys Inc
Publication of BR0210547A publication Critical patent/BR0210547A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/732—Pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
BR0210547-0A 2001-06-22 2002-06-21 Método e material para tratar doenças imunes BR0210547A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US30036001P 2001-06-22 2001-06-22
US10/176,022 US20030004132A1 (en) 2001-06-22 2002-06-20 Method and material for treating immune diseases
PCT/US2002/019886 WO2003000195A2 (en) 2001-06-22 2002-06-21 Method and material for treating immune diseases

Publications (1)

Publication Number Publication Date
BR0210547A true BR0210547A (pt) 2004-05-25

Family

ID=26871794

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0210547-0A BR0210547A (pt) 2001-06-22 2002-06-21 Método e material para tratar doenças imunes

Country Status (8)

Country Link
US (1) US20030004132A1 (OSRAM)
EP (1) EP1408989A2 (OSRAM)
JP (1) JP2004536825A (OSRAM)
CN (1) CN100558368C (OSRAM)
BR (1) BR0210547A (OSRAM)
CA (1) CA2451885A1 (OSRAM)
IL (1) IL159462A0 (OSRAM)
WO (1) WO2003000195A2 (OSRAM)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006522163A (ja) 2003-04-07 2006-09-28 グリコジェネシス， インク． ガレクチンアンタゴニストの組成物と使用
US20040223971A1 (en) * 2003-04-07 2004-11-11 Glycogenesys, Inc. Composition and uses of galectin antagonists
US20050158321A1 (en) * 2003-12-17 2005-07-21 Entelos, Inc. Treatment of rheumatoid arthritis with galectin-3 antagonists
EP1765874A1 (en) 2004-03-26 2007-03-28 Glycogenesys, Inc. Modified pectins, compositions and methods related thereto
CN103718046B (zh) * 2011-03-17 2016-10-12 重症监护诊断股份有限公司 预测不良临床结果的风险的方法
AU2012363033B2 (en) 2011-12-28 2016-06-02 Galectin Therapeutics, Inc. Composition of novel carbohydrate drug for treatment of human diseases
WO2013184892A1 (en) 2012-06-06 2013-12-12 Galectin Therapeutics, Inc. Galacto-rhamnogalacturonate compositions for the treatment of diseases associated with elevated inducible nitric oxide synthase
WO2014043708A1 (en) 2012-09-17 2014-03-20 Traber Peter G Method for enhancing specific immunotherapies in cancer treatment
ES2698101T3 (es) 2012-10-10 2019-01-31 Galectin Therapeutics Inc Compuestos de carbohidrato con restos de galactosa para el tratamiento de la nefropatía diabética y trastornos asociados
US12390486B2 (en) 2012-12-20 2025-08-19 Henry Ford Health System Method for treating diastolic heart failure by inhibiting galectin-3
US9907814B2 (en) 2012-12-20 2018-03-06 Henry Ford Health System Method for treating diastolic heart failure by inhibiting galectin-3
WO2014130648A1 (en) 2013-02-20 2014-08-28 Galectin Therapeutics, Inc. Method for treatment of pulmonary fibrosis
CA3088736A1 (en) * 2018-01-21 2019-07-25 Rensselaer Polytechnic Institute Method of treating galectin-3 dependent disorders
EP3813883A1 (en) 2018-06-29 2021-05-05 Glykos Biomedical Oy Conjugates
WO2021123506A1 (en) 2019-12-18 2021-06-24 Glykos Biomedical Oy Stabile conjugate

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5490991A (en) * 1986-07-03 1996-02-13 Advanced Magnetics, Inc. Directed delivery of radioprotectants using a receptor specific carrier
CA2065265A1 (en) * 1990-06-27 1991-12-28 Tadao Shoji Alkylated oligosaccharides and acetyl derivatives of the same
US5498702A (en) * 1993-12-16 1996-03-12 California Natural Products Treated pectinic acid process and product
US5834442A (en) * 1994-07-07 1998-11-10 Barbara Ann Karmanos Cancer Institute Method for inhibiting cancer metastasis by oral administration of soluble modified citrus pectin
US5831052A (en) * 1997-05-07 1998-11-03 Incyte Pharmaceuticals, Inc. New human translocation associated protein
US6258383B1 (en) * 1998-08-14 2001-07-10 Lactoferrin Products Company Dietary supplement combining colostrum and lactoferrin in a mucosal delivery format
US6500807B1 (en) * 1999-02-02 2002-12-31 Safescience, Inc. Modified pectin and nucleic acid composition
US6680306B2 (en) * 2001-06-21 2004-01-20 Glycogenesys, Inc. Method for enhancing the effectiveness of cancer therapies

Also Published As

Publication number Publication date
WO2003000195A3 (en) 2003-03-20
CA2451885A1 (en) 2003-01-03
JP2004536825A (ja) 2004-12-09
IL159462A0 (en) 2004-06-01
EP1408989A2 (en) 2004-04-21
US20030004132A1 (en) 2003-01-02
WO2003000195A2 (en) 2003-01-03
CN100558368C (zh) 2009-11-11
CN1543352A (zh) 2004-11-03

Similar Documents

Publication Publication Date Title
BR9807083A (pt) Antagonistas ao receptor de il-8
WO2003000195A3 (en) Method and material for treating immune diseases
BR9909908A (pt) Derivados de ácidos graxos de ácidos biliares e derivados de ácidos biliares
AU4492489A (en) Glucan dietary additives
EP2298811A3 (en) Human anti-ifn-gamma neutralizing antibodies as selective ifn-gamma pathway inhibitors
BR9810944A (pt) Controle de sìndrome de intestino acìdico
BR9406178A (pt) Composição de amino-açucar e glicosaminoglicano para o tratamento e restauração de tecido conectivo
BR9608612A (pt) Vacina compreendendo um conjugado de antígeno de polissacarídeo - proteína portadora e proteína portadora livre
WO1997017446A3 (en) HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF
PT942740E (pt) Terapia de combinacao utilizando uma proteina de ligacao de tnf para tratamento de doencas mediadas por tnf
BR0011000A (pt) Métodos para prevenir ou tratar uma doença associada com depósitos amilóides de ab no cérebro de um paciente, para avaliar um anticorpo quanto á atividade de remoção de uma entidade biológica fisicamente associada com um antìgeno e para detectara um depósito amilóide em um paciente, composição farmacêutica, e, conjunto de diagnóstico
BR9809951A (pt) Método para tratamento da obesidade
PT833911E (pt) Anticorpos anti-factor tecidular enxertados com cdr e metodos para a sua utilizacao
EP1242115A4 (en) CHEMICALLY PROGRAMMABLE IMMUNITY
BR9913400A (pt) Formulação oral de liberação imediata na forma sólida de um inibidor de trombina, uso de um inibidor de trombina baseado em peptìdeo de baixo peso molecular, processos para a profilaxia e/ou o tratamento de trombo-embolismo, e para a preparação de uma formulação oral de liberação imediata, e, uso de uma carga escolhida do grupo consistindo de um derivado de celulose, e um derivado de amido
CO5130025A1 (es) METODO PARA TRATAR ATEROESCLEROSIS EMPLEANDO UN INHIBIDOR DE ap2 Y COMBINACION
EP0401903A3 (en) The use of vanilloids for the treatment of respiratory diseases or disorders
PT758241E (pt) Utilizacao de certos derivados de acido metanobisfosfonico para impedir o desprendimento de proteses e a migracao de proteses
CY1107436T1 (el) Χρηση των αναστολεων της ενδοτοξινης για την θεραπεια της καχεξιας
BR9805318A (pt) Método para tratamento de infecções dos olhos com azitromicina.
Azofeifa et al. Ability of fucoidan to prevent muscle necrosis induced by snake venom myotoxins: Comparison of high-and low-molecular weight fractions
BR0010802A (pt) Antagonistas de receptor il-8
KR960030947A (ko) src SH2 특이성 화합물의 골흡수 질환 치료 용도
RU2223782C2 (ru) Средство для лечения патологического костного метаболизма
BR9807085A (pt) Antagonistas de receptor de il-8

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A,6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2029 DE 24/11/2009.